AAS
IDNA icon

Ameritas Advisory Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Ameritas Advisory Services’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$410 – 2500
2025
Q2 		$410 Buy
+20
New +$403 ﹤0.01% 2715

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameritas Advisory Services's IDNA Position: Q3 2025 in Review

Ameritas Advisory Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2025, closing a stake of 20 shares — an estimated $410 sold.

Ameritas Advisory Services first reported a position in IDNA in Q2 2025 and held it in 1 quarter. The position peaked at $410 in Q2 2025. 51 funds tracked by Wall St. Rank hold IDNA as of Q3 2025.

  • Ameritas Advisory Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 20 iShares Genomics Immunology and Healthcare ETF shares in Q3 2025, an estimated $410.
  • Ameritas Advisory Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2025 and held it in 1 quarter.
  • Ameritas Advisory Services's iShares Genomics Immunology and Healthcare ETF position peaked at $410 in Q2 2025.
  • 51 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.